Leading the Way in Life Science Technologies

GEN Exclusives

More »

November 1, Vol. 29, No. 19

  • Feature Articles

    • Search Intensifies for Diabetes Drugs
    • Nina Flanagan
    • The competition to develop new therapeutics targeting metabolic disease is heating up Here’s why: the latest estimates from the American Diabetes Association state that there are nearly 24 million Americans with diabetes In addition, approximately 32% of American adults are ... more »
    • Sample Prep Advances Extend Mass Spec
    • K. John Morrow Jr.
    • Sample preparation for mass spectrometry has been the topic of several recent symposia extensively covered in the pages of GEN Mass spectrometry has grown over the years into an essential tool for macromolecular characterization due to the development of more ... more »
    • New Capabilities Fortify Biodefense Tools
    • Gail Dutton
    • Clinical detection methods are taking to the field, boosting the capabilities of point-of-care biodetection devices for clinical use as well as battlefield diagnoses Speakers at Select Biosciences’ “Advances in Biodetection Technology” held in London last month outlined their work in ... more »
    • Animal Imaging Transforms Development
    • Elizabeth Lipp
    • Rapidly evolving imaging technologies were front and center at the “World Molecular Imaging Congress”, which was held recently in Montreal This year’s meeting provided a timely forum to discuss the use of imaging in drug development, an application that is ... more »
    • Third Option for Stem Cell Research Emerges
    • Kenneth Aldrich
    • Remember this term: Parthenogenesis This six-syllable word could be the answer to controversy-free stem cell research Though the general public is well aware of the medical potential and controversies surrounding embryonic stem cells and iPS cells (induced pluripotent stem cells), ... more »
  • Columns

    • Preserving the Integrity of Statistics
    • Zachary N. Russ
    • Ronald Coase, the Nobel Prize-winning economist, is commonly credited with the adage, “If you torture the data long enough, it will confess” I was recently reminded of Dr Coase’s astute observation while relaxing with a group of bio-buddies after a ... more »
    • Certainty Not Required for Inventorship
    • William L. Warren
      S Cao
    • Modern life science research frequently requires collaborative research efforts between colleagues and even institutions But which collaborators should be named as co-inventors on a resulting patent application? The simple answer is: whoever contributed to the conception of the claimed invention... more »
    • Gains Steadily Building in Biotech Sector
    • G Burrill
    • For the second consecutive quarter we have seen positive gains for biotech, fueling the notion that the worst of the economic woes that have assailed the sector may finally be over While biotech’s year-to-date performance still lags behind the general ... more »
    • GEN's GREENbiopharma Conference Focuses on the E...
    • A sustainable business is one that engages in processes and manufacturing activities that address current environmental concerns while maintaining a profit There is a rapidly growing community of professionals in academia, industry, policy, and government who have embraced this responsibility ... more »